Gene therapy of immunodeficiency disorders;Thérapie génique des déficits immunitaires

Bulletin de l'Academie Nationale de Medecine

Volumn 184, Issue 7, 2000, Pages 1417-1430

  Fischer, Alain ^a   Hacein Bey, Salima ^b   Le Deist, Françoise ^b   De Saint Basile, Geneviève ^b   De Villartay, Jean Pierre ^b   Cavazzana Calvo, Marina ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

(Index Medicus); Gene therapy; Immunologic deficiency syndromes; Lentivirus; Lymphocytes

Indexed keywords

GENE THERAPY; GENETICS; HUMAN; IMMUNE DEFICIENCY; METHODOLOGY; REVIEW;

GENE THERAPY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 0034559717     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. FISCHER A., MALISSEN B. - Natural and engineered disorders of lymphocyte development. Science, 1998, 280, 237-243.
2. CHU D.H., MORITA C.T., WEISS A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev, 1998, 165, 167-180.
3. REITH W., MUHLETHALER-MOTTET A., MASTERNAK K., VILLARD J., MACH B. - The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression. Microbes Infect, 1999, I, 839-846.
4. SNAPPER S B., ROSEN F. S. - The Wiskott-Aldrich syndrome protein (WASP), roles in signaling and cytoskeletal organization. Annu Rev Immunol, 1999, 17, 905-929.
5. NOTARANGELO L.D., HAYWARD A. R.X. - Linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol, 2000, 120, 399-405.
6. SEGAL B.H., LETO T.L., GALLIN J.I., MALECH H.L., HOLLAND S.M. - Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore), 2000, 79, 170-200.
7. BUCKLEY R.H., SCHIFF S. E., SCHIFF R.I., MARKERT L., WILLIAMS L.W., ROBERTS J.L., MYERS L.A., WARD F.E. - Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency [see comments). N Engl J Med, 1999, 340, 508-516.
8. HADDAD E., LE DEIST F., AUCOUTURIER P., CAVAZZANA-CALVO M., BLANCHE S., DE SAINT BASILE G., FISCHER A. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells, A single-center study of 22 patients. Blood, 1999, 94, 2923-2930.
9. PATEL D.D., GOODING M.E., PARROTT R.E., CURTIS K.M., HAYNES B.F., BUCKLEY R.H Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med, 2000, 342, 1325-1332.
10. WEISSMAN I.L Translating stem and progenitor cell biology to the clinic : barriers and opportunities. Science, 2000, 287, 1442-1446
11. BLAESE R.M., CULVER K.W., MILLER A.D., CARTER C.S., FLEISHER T., CLERICI M., SHEARER G., CHANG L., CHIANG Y., TOLSTOSHEV P. et al. - T lymphocyte-directed gene therapy for ADA -SCID initial trial results after 4 years. Science, 1995, 270, 475-480.
12. KAWAMURA N., ARIGA T., OHTSU M., KOBAYASHI I., YAMADA M., TAME A., FURUTA H., OKANO M., EGASHIRA M., NIIKAWA N., KOBAYASHI K., SAKIYAMA Y. - In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy, role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient. J Immunol, 1999, 163, 2256-2261.
13. MILLER A.D. - Retroviral vectors. Curr Top Microbiol Immunol, 1992, 158, 1-24.
14. MIYOSHI H., SMITH K.A., MOSIER D.E., VERMA I.M., TORBETT B.E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science, 1999, 28, 682-686.
15. CASE S.S., PRICE M.A., JORDAN C.T., YU X.J., WANG L., BAUER G., HAAS D.L., XU D., STRIPECKE R., NALDINI L., KOHN D.B., CROOKS G.M. - Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA., 1999, 96, 2988-2993.
16. ZENNOU V., PETIT C., GUETARD D., NERHBASS U., MONTAGNIER L., CHARNEAU P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell, 2000, 101, 173-185.
17. FOLLENZI A., AILLES L.E., BAKOVIC S., GEUNA M., NALDINI L. - Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 po1 sequences. Nat Genet, 2000, 25, 217-222.
18. BROWN M.P., TOPHAM D .J., SANGSTER M.Y., ZHAO J., FLYNN K.J., SURMAN S L., WOODLAND D.L., DOHERTY P.C., FARR A.G., PATTENGALE P.K., BRENNER M.K - Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med, 1998, 4, 1253-1260.
19. LEONARD W.J. - The molecular basis of X-linked severe combined immunodeficiency, defective cytokine receptor signaling. Annu Rev Med, 1996, 47, 229-239.
20. WENGLER G.S., ALLEN R.C., PAROLINI O., SMITH H., CONLEY M.E. - Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. J Imnnmol, 1993, 150, 700-704.
21. HACEIN-BEY H., CAVAZZANA-CALVO M., LE DEIST F., DAUTRY-VARSAT A., HIVROZ C., RIVIERE I., DANOS O., HEARD J.M., SUGAMURA K., FISCHER A., DE SAINT BASILE G. - gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood, 1996, 87, 3108-3116.
22. BUNTING K.D., SANGSTER M.Y., IHLE J.N., SORRENTINO B.P. - Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer [see comments]. Nat Med, 1998, 4, 58-64.
23. BUNTING K.D., FLYNN K.J., RIBERD J.M., DOHERTY P.C., SORRENTINO B.P. - Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency. Proc Natl Acad Sci USA, 1999, 96, 232-237.
24. STEPHAN V., WAHN V., LE DEIST F., DIRKSEN U., BROKER B., MULLER-FLECKENSTEIN I., HORNEFF G., SCHROTEN H., FISCHER A., DE SAINT BASILE G. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med, 1996, 355, 1563-1567.
25. BOUSSO P., WAHN V., DOUAGI I., HORNEFF G., PANNETIER C., LE DEIST F., ZEPP F., NIEHUES T., KOURILSKY P., FISCHER A., DE SAINT BASILE G. - Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. Proc Natl Acad Sci USA, 2000, 97, 274-278.
26. HIRSCHHORN R., YANG D.R., PUCK J.M., HUIE M.L., JIANG C.K., KURLANDSKY L.E. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency [see comments]. Nat Genet, 1996, 13, 290-295.
27. ROHRER J., CONLEY M.E. - Correction of X-linked immunodeficient mice by competitive reconstitution with limiting numbers of normal bone marrow cells. Blood, 1999, 94, 3358-3365.
28. RIVIERE I., BROSE K., MULLIGAN R.C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA, 1995, 92, 6733-6737.
29. HALENE S., KOHN D.B. - Gene therapy using hematopoietic stem cells, sisyphus approaches the crest. Human Gene Therapy, 2000, 11, 1259-1267.
30. ROBBINS P.B., SKELTON D. C., YU X.J., HALENE S., LEONARD E.H., KOHN D.B. - Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc Natl Acad Sci USA, 1998, 95, 10182-10187.
31. HALENE S., WANG L., COOPER R.M., BOCKSTOCE D.C., ROBBINS P.B., KOHN D.B. - Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood, 1999, 94, 3349-3357.
32. COSSET F.L., MORLING, F.J., TAKEUCHI Y., WEISS R.A., COLLINS M.K., RUSSELL S.J. - Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol, 1995, 69, 6314-6322.
33. MACNEILL E.C., HANENBERG H., POLLOK K.E., VAN DER LOO J.C., BIERHUIZEN M.F., WAGEMAKER G., WILLIAMS D.A. - Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296. J Virol, 1999, 73, 3960-3967.
34. KIEM H.P., HEYWARD S., WINKLER A., POTTER J., ALLEN J.M., MILLER A.D., ANDREWS R.G. -Gene transfer into marrow repopulating cells, comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood, 1997, 90, 4638-4645.
35. DAO M.A., HANNUM C.H., KOHN D.B., NOLTA J.A. - FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood, 1997, 89, 446-456.
36. HENNEMANN B., CONNEALLY E., PAWLIUK R., LEBOULCH P., ROSE-JOHN S., REID D., CHUO J.Y., HUMPHRIES R.K., EAVES C.J. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. Exp Hematol, 1999, 27, 817-825.
37. DUNBAR C.E., SEIDEL N.E., DOREN S., SELLERS S., CLINE A.P., METZGER M.E., AGRICOLA B.A., DONAHUE R.E., BODINE D.M. - Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA, 1996, 93, 11871-11876.
38. HANENBERG H., XIAO X.L., DILLOO D., HASHINO K., KATO I., WILLIAMS D.A. - Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med, 1996, 2, 876-882.
39. KIEM H.P., ANDREWS R.G., MORRIS J., PETERSON L., HEYWARD S., ALLEN J.M., RASKO J.E., POTTER J., MILLER A.D. - Improved gene transfer into baboon marrow repopulatingcells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood, 1998, 92, 1878-1886.
40. DAO M.A., HASHINO K., KATO I., NOLTA J.A. - Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood, 1998, 92, 4612-4621.
41. ROSENZWEIG M., MACVITTIE T.J., HARPER D., HEMPEL D., GLICKMAN R.L., JOHNSON R.P., FARESE A.M., WHITING-THEOBALD N., LINTON G.F., YAMASAKI G., JORDAN C.T., MALECH H L. - Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood, 1999, 94, 2271-2286.
42. KOHN D.B., HERSHFIELD M.S., CARBONARO D., SHIGEOKA A., BROOKS J., SMOGORZEWSKA E.M., BARSKY L.W., CHAN R., BUROTTO F., ANNETT G., NOLTA J.A., CROOKS G., KAPOOR N., ELDER M., WARA D., BOWEN T., MADSEN E., SNYDER F.F., BASTIAN J., MUUL L., BLAESE R.M., WEINBERG K., PARKMAN R. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med, 1998, 4, 775-780.
43. CANDOTTI F., JOHNSTON J.A., PUCK J.M., SUGAMURA K., O'SHEA J.J., BLAESE R.M. Retroviral-medialcd gene correction for X-linked severe combined immunodeficiency. Blood, 1996, 87, 3097-3102.
44. TAYLOR N., URIBE L., SMITH S., JAHN T., KOHN D.B., WEINBERG K. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene. Blood, 1996, 87, 3103-3107.
45. CAVAZZANA-CALVO M., HACEIN-BEY S., DE SAINT BASILE G., DE COENE C., SELZ F., LE DEIST F., FISCHER A. - Role of interleukin-2 (IL-2)., IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood, 1996, 88, 3901-3909.
46. HACEIN-BEY S., BASILE G.D., LEMERLE J., FISCHER A., CAVAZZANA-CALVO M. - gammac gene transfer in the presence of stem cell factor, FLT-3L, interleukin-7 (IL-7), IL-1, and IL-15 cytokines restores T-cell differentiation from gammac(-) X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures. Blood, 1998, 92, 4090-4097.
47. LO M., BLOOM M.L., IMADA K., BERG M., BOLLENBACHER J.M., BLOOM E.T., KELSALL B.L., LEONARD W.J. - Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach. Blood, 1999, 94, 3027-3036.
48. SOUDAIS C., TUSJINO S., SHARARA L.I., GUY-GRAND D., TANIGUCHI T., FISCHER A., DI SANTO J.P - Stable and functional lymphoid reconstitution common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer. Blood, 2000, 95, 3071-3077.
49. WHITWAM T., HASKINS M.E., HENTHORN P.S., KRASZEWSKI J.N., KLEIMAN S.E., SEIDEL N.E., BODINE D.M., PUCK J.M. - Retroviral marking of canine bone marrow, long-term., high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes. Blood, 1998, 92, 1565-1575.
50. CAVAZZANA-CALVO M., HACEIN-BEY S., DE SAINT BASILE G., GROSS F., YVON E., NUSBAUM P., SELZ F., HUE C., CERTAIN S., CASANOVA J.L., Bousso P., LE DEIST F., FISCHER A. - Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 2000, 288, 669-672.
51. BUCKLEY R.H. - Gene therapy for human SCID, dreams become reality [In Process Citation]. Nat Med, 2000, 6, 623-624.
52. MACCHI P., VILLA A., GILLANI S., SACCO M.G., FRATTINI A., PORTA F., UGAZIO A.G., JOHNSTON J.A., CANDOTTI F., O'SHEA J.J. et al. - Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature, 1995, 377, 65-68.
53. CANDOTTI F., OAKES S.A., JOHNSTON J.A., NOTARANGELO L.D., O'SHEA J.J., BLAESE R.M. - In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J Exp Med, 1996, 183, 2687-2692.
54. PUEL A., ZIEGLER S.F., BUCKLEY R.H., LEONARD W.J. Defective IL7R expression in T(-) B(+)NK(+) severe combined immunodeficiency. Nat Genet, 1998, 20, 394-397.
55. NOTARANGELO L. D., VILLA A., SCHWARZ K. - RAG and RAG defects. Curr Opin Immunol, 1999, 11, 435-442.
56. TAYLOR N., BACON K.B., SMITH S., JAHN T., KADLECEK T.A., URIBE L., KOHN D.B., GELFAND E.W., WEISS A., WEINBERG K. Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene. J Exp Med, 1996, 184, 2031-2036.
57. LIN S.Y., ARDOUIN L., GILLET A., MALISSEN M., MALISSEN B. The single positive T cells found in CD3-zeta/eta-/-mice overtly react with self-major histocompatibility complex molecules upon restoration of normal surface density of T cell reccptor-CD3 complex. J Exp Med, 1997, 185, 707-715.
58. BRADLEY M.B., FERNANDEZ J.M., UNGERS G., DIAZ-BARRIENTOS T., STEIMLE V., MACH B., O'REILLY R., LEE J.S. - Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA. J Immunol, 1997, 159, 1086-1095.
59. CANDOTTI F., FACCHETTI F., BLANZUOLI L., STEWART D.M., NELSON D.L., BLAESE R.M. -Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations. Gene Ther, 1999, 6, 1170-1174.
60. HUANG M.M., TSUBOI S., WONG A., YU X.J., OH-EDA M., DERRY J.M., FRANCKE U., FUKUDA M., WEINBERG K.I., KOHN D.B. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Gene Ther, 2000, 7, 314-320.
61. BARRY S.C., SEPPEN J., RAMESH N., FOSTER J.L., SEYAMA K., OCHS H. D., GARCIA J.V., OSBORNE W.R. - Lentiviral and murine retroviral transduction of T cells for expression of human CD40 ligand. Hum Gene Ther, 2000, 11, 323-332.
62. MALECH H.L. - Progress in gene therapy for chronic granulomatous disease. J Infect Dis, 1999, 179, Suppl 2, S318-325.